In our cohort of solely stage 5 CKD patients, the baseline Hb level was 9.3 ± 1.5 g/dL and 10.4 ± 1.8 g/dL in ESA users and non-users, indicating at least moderate severity of anemia. The gene discussed is GSTM1; the disease is anemia (phenotype).